Classifications

• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
  • C12N15/09—Recombinant DNA-technology
  • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
  • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
  • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
  • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
  • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
  • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
  • C12N15/8274—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for herbicide resistance
  • C12N15/8275—Glyphosate

Definitions

• the present invention relates generally to molecular plant biology.
• Resistance phenotypes may also be subject to additional environmental variations and/or to differential regulation of a resistance gene within plat tissues, organs, cellular compartments etc. Accordingly, methods are needed in the art to improve transgenes such that the encoded enzymes are functional across a broader spectrum of environmental conditions ⁇ e.g., temperature, soil acidity, etc.) and/or physiological conditions ⁇ e.g., pH, concentration of an enzyme substrate or cofactor, etc.). To meet this need, the present invention provides methods of expressing two or more enzymes that perform a same or similar function in a plant, wherein the two or more enzymes have difference kinetic parameters, to achieve optimal enzyme activity across a range of environmental and/or physiological conditions.
• environmental conditions e.g., temperature, soil acidity, etc.
• physiological conditions e.g., pH, concentration of an enzyme substrate or cofactor, etc.
• the present invention provides methods and compositions for improved enzyme activity in transgenic plants.
• the invention is useful as applied to plants such as agricultural plants, including both monocots and dicots.
• transgenic plants wherein the plants have improved enzyme activity.
• a transgenic plant may comprise at least (a) a first heterologous polynucleotide encoding a first polypeptide capable of conferring a trait of interest, and (b) a second heterologous polynucleotide encoding a second polypeptide capable of conferring said trait of interest, wherein said first and second polynucleotides are stably expressed in said plant, and wherein said plant shows said trait of interest over a broader range of a physiological or environmental condition as compared to a plant comprising either said first or second polynucleotide expressed alone and subject to said range of a physiological or environmental condition.
• a transgenic plant of the invention may comprise at least (a) a first heterologous polynucleotide encoding a first polypeptide capable of conferring herbicide resistance, and (b) a second heterologous polynucleotide encoding a second polypeptide capable of conferring said herbicide resistance, wherein said first and second polynucleotides are stably expressed in said plant, and wherein said plant shows said herbicide resistance over a broader range of a physiological or environmental condition as compared to a plant comprising either said first or second polynucleotide expressed alone and subject to said range of a physiological or environmental condition.
• such a method may comprise introducing into said plant at least (a) a first heterologous polynucleotide encoding a first polypeptide capable of conferring said trait of interest, and (b) a second heterologous polynucleotide encoding a second polypeptide capable of conferring said trait of interest, wherein said first and second polynucleotides are stably expressed in said plant, and wherein said plant shows said trait of interest over a broader spectrum of a physiological or environmental condition as compared to a plant comprising either said first or second polynucleotide expressed alone and subject to said spectrum of a physiological or environmental condition.
• such a method may comprise (a) providing a transgenic plant comprising a first heterologous polynucleotide encoding a first polypeptide capable of conferring said trait of interest, and (b) introducing into said plant at least a second heterologous polynucleotide encoding a second polypeptide capable of conferring said trait of interest, wherein said first and second polynucleotides are stably expressed in said plant, and wherein said plant shows said trait of interest over a broader spectrum of a physiological or environmental condition as compared to a plant comprising either said first or second polynucleotide expressed alone and subject to said spectrum of a physiological or environmental condition.
• a representative method of the invention comprises introducing into said plant at least (a) a first heterologous polynucleotide encoding a first polypeptide capable of conferring resistance to said herbicide, and (b) a second heterologous polynucleotide encoding a second polypeptide capable of conferring resistance to said herbicide, wherein said first and second polynucleotides are stably expressed in said plant, and whereby said plant is herbicide resistant over a broader spectrum of a physiological or environmental condition as compared to a plant comprising either said first or second polynucleotide expressed alone and subject to said range of a physiological or environmental condition.
• the method may comprise (a) providing a transgenic plant comprising a first heterologous polynucleotide encoding a first polypeptide capable of conferring resistance to said herbicide, and (b) introducing into said plant at least a second heterologous polynucleotide encoding a second polypeptide capable of conferring resistance to said herbicide, wherein said first and second polynucleotides are stably expressed in said plant, and whereby said plant is herbicide resistant over a broader spectrum of a physiological condition as compared to a plant comprising either said first or second polynucleotide expressed alone and subject to said range of a physiological or environmental condition.
• methods are provided for increasing plant vigor or yield by (a) providing a plant having improved enzymatic properties as described herein; and (b) treating the plant with an effective amount of said herbicide.
• a plant having improved enzyme activity can encode first and second polypeptides that each confer resistance to glyphosate.
• a plant can comprise first and second polypeptides that encode EPSP synthase enzymes, e.g., any one of SEQ ID NOs: 2, 4, 6, or 8, or any one of the amino acid sequences depicted in Figures 5A-5P.
• Figure 1 is the activity of glyphosate resistant EPSP synthase enzymes derived from Brevundomonas vesicularis (GRG8, SEQ ID NO:2), Arthrobacter globifortnis (GRG23, SEQ ID NO:4), Enterobacteriaceae sp. (GRGl, SEQ ID NO:6) and Sulfolobus solfataricus (GRG20, SEQ ID NO:8) across a broad temperature spectrum.
• EPSP synthase enzyme activity at each temperature is plotted as a percentage of the maximal activity.
• Figure 2 is a graph depicting the activity of glyphosate resistant EPSP synthase enzymes derived from Arthrobacter globiformis (GRG23, SEQ ID NO:4) and Enterobacteriaceae sp. (GRGl, SEQ ID NO:6) as a function of the concentration of salt, expressed in mM.
• Figure 3 shows a graph depicting the rate of product formation as a function of substrate concentration for a plant expressing equal amounts of one or both of two enzymes with complementary properties.
• the 'El ' curve represents the rate of product formation from a plant expressing a said quantity of enzyme 1 , where enzyme 1 has a Km for its substrate of 5 ⁇ M and a k cat of 25 sec "1 .
• the 'E2' curve represents the rate of product formation from a plant expressing a said quantity of E2, where E2 has a Km for its substrate of 30 ⁇ M and a k cat of 50 sec "1 .
• the 'El +E2' curve represents the rate of product formation from a plant expressing a said quantity of both El and E2.
• Figure 4 is a graph depicting the rate of product formation as a function of inhibitor concentration for a plant expressing equal amounts of one or both of two enzymes with complementary properties.
• the 'El ' curve represents the rate of product formation from a plant expressing a said quantity of enzyme 1, where El has a ki of 250 ⁇ M, a Km for its substrate of lOuM, and a k cat of 25 sec "1 .
• the 'E2' curve represents the rate of product formation from a plant expressing a said quantity of E2, where E2 has a ki of 50 ⁇ M, a Km for its substrate of 10 ⁇ M, and a k cat of 50 sec "1 .
• the 'El +E2' curve represents the rate of product formation from a plant expressing a said quantity of both El and E2 as a function of the concentration of inhibitor.
• the concentration of substrate is fixed (in this case, 20 ⁇ M).
• Figures 5A-5P depict nucleotide and amino acid sequences of the grg8, grg23, grgl, and grg20 sequences described in Example 1.
• the present invention provides methods of expressing two or more enzymes that perform a same or similar function in a plant, wherein the two or more enzymes have difference kinetic parameters, to achieve optimal enzyme activity across a range of environmental and/or physiological conditions. For example, an increase in activity of certain metabolic enzymes can result in increased or accelerated plant growth and development. Similarly, an increase in activity of an enzyme that confers resistance to herbicides, insects, or disease, enhances plant protective mechanisms to enable plant growth. Plants, plant tissues, and seeds prepared by the disclosed method are also provided.
• compositions of the invention include plants or plant parts comprising a first heterologous polynucleotide encoding a first polypeptide and a second heterologous polynucleotide encoding a second polypeptide that performs a same or similar enzymatic function as the first polypeptide, and wherein expression of the first and second polynucleotides increases enzyme activity of the polypeptides over a broader range of environmental and/or physiological conditions than expression of either polynucleotide alone.
• Environmental and/or physiological conditions include any conditions that may result in variable activity of an enzyme of interest in a plant.
• the descriptors environmental and physiological are not mutually exclusive as changes in the environment can also affect physiological conditions within a plant.
• enzymes in different plant organs ⁇ e.g., leaves, buds, stems, flowers, fruits, tubers, rhizomes
• plant tissues e.g., dermal, ground, or vascular tissues
• plant cellular compartments e.g., cytoplasm, chloroplast, mitochondria
• Representative conditions include temperature, pH, concentration of an enzyme substrate or cofactor, salt concentration, concentration of free radicals or free radical donors, and concentration of an enzyme inhibitor or catalyst.
• the range of conditions at which each individual enzyme is active can be exclusive or overlapping.
• the optimal enzyme activity e.g., the percentage of maximum activity
• the optimal enzyme activity is different among the individual enzymes such that the combined enzyme activity is increased over a broader range of conditions as compared to the enzyme activity of any one of the individual enzymes.
• an increase in enzyme activity includes any significant increase of activity or function of the polypeptide of interest, for example, an increase in the inhibition or stimulation of biological or chemical reactions within a cell or organism that can lead to enhanced or diminished metabolic activity, growth, or development.
• Assays to measure enzyme activity are well-known in the art.
• An increase in enzyme activity observed in the disclosed multiple-component expression system i.e., plants expressing two or more polynucleotides encoding polypeptides with a same or similar function but different kinetic properties
• an increase in enzyme activity observed in the disclosed multiple-component expression system can comprise a level of activity that is about 2-fold or more greater than a level of activity observed with any single component, for example, about 5-fold or more, or about 10-fold or more, or about 25-fold or more, or about 50- fold or more, or about 100-fold or more, or about 200-fold or more, or about 500-fold or more, or about 1000-fold or more.
• Enzymes of a multiple component expression system may be referred to as first and second enzymes (or first, second, and third enzymes, etc.). The designations of one enzyme as a "first" enzyme and another enzyme as a "second" enzyme are merely arbitrary, the significance of the two enzymes being the differential enzymatic properties as described herein.
• a broader range of environmental and/or physiological conditions refers to any extension in the range of the condition, either above or below or both, within which an enzyme performs its biological function.
• expression of two polynucleotides encoding a polypeptide of interest, wherein the first and second polypeptide have different temperature optima resulting in an increase in enzyme activity of the polypeptide of interest over a temperature range that is at least about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65°C or more than when either of the polynucleotides is expressed alone.
• each polypeptide employed in the methods of the invention can have enzyme activity with a temperature optimum within the temperature range of about 0 0 C to about 10 0 C, from about 10 0 C to about 20 0 C, from about 20 0 C to about 30 0 C, from about 30 0 C to about 40 0 C, from about 40 0 C to about 50 0 C, from about 50 0 C to about 60 0 C, or from about 60 0 C to about 70 0 C.
• Plants expressing the two or more polynucleotides encoding polypeptides with different temperature optima will have an elevated level of enzyme activity based upon the combined activities of the enzymes as the temperature changes throughout the day or season.
• a transgenic plant of the invention may comprise a plant expressing a first polypeptide having optimal enzyme activity within a temperature range of about 5°C to about 35°C, or a plant expressing a second polypeptide having optimal enzyme activity at a higher temperature as compared to the first polypeptide and within a temperature range of about 20 0 C to about 60 0 C.
• a transgenic plant of the invention may comprise a plant expressing a first polypeptide having optimal enzyme activity within a temperature range of about 10 0 C to about 30 0 C and a second polypeptide having optimal enzyme activity at a higher temperature as compared to the first polypeptide and within a temperature range of about 25°C to about 50 0 C.
• Representative plants having the above-noted features include a plant expressing a first polypeptide having an amino acid sequence of SEQ ID NO:2, and a second polypeptide having an amino acid of SEQ ID NO:4, 6, or 8, and a plant expressing a first polypeptide having an amino acid sequence of SEQ ID NO:4, and a second polypeptide having an amino acid of SEQ ID NO: 6 or 8. See Figure 1.
• One non-limiting method of increasing the temperature spectrum within which an enzyme performs its biological function is to introduce into an organism one or more polynucleotides encoding an enzyme of interest derived from psychrophilic and/or thermophilic organisms.
• Psychrophilic organisms such as Bacillus globisporus and Shewanella sp., are organisms that thrive at temperatures as low as or lower than 0 0 C.
• Thermophilic organisms such as Bacillus cadotenax, Thermus thermophilus, and Aquifex aeolicus, thrive at higher temperatures, typically above 120 0 C.
• Several metabolic enzymes have been isolated from such organisms (see e.g., U.S. Patent Nos.
• U.S. Patent No. 6,385,546 further describes a method to increase the thermophilicity (e.g., the ability to function at or above the optimal temperature for the native polypeptide) or psychrophilicity (e.g., the ability to function at or below the optimal temperature for the native polypeptide) of any enzyme by changing amino acid residues that affect the stability of the polypeptide without modifying or affecting the active or binding sites of the polypeptide.
• thermophilicity e.g., the ability to function at or above the optimal temperature for the native polypeptide
• psychrophilicity e.g., the ability to function at or below the optimal temperature for the native polypeptide
• the present invention encompasses such modifications when intended to increase the desired activity of an enzyme by introducing into a plant at least two polynucleotides encoding at least two polypeptides, wherein expression of the at least two polynucleotides increases enzyme activity over a broader spectrum of temperatures than expression of either polynucleotide alone.
• a two-component expression system can comprise a first enzyme with a relatively low Km for substrate, and a relatively low catalytic rate constant ("turnover number"; Kcat), and a second enzyme having a relatively higher Km for substrate and a relatively higher catalytic rate constant as compared to the first enzyme.
• the enzyme inhibition constant for a competitive inhibitor may also vary between the first and second enzymes. Plants that stably express polynucleotides encoding both enzymes will show higher levels of enzyme activity over a broader spectrum of substrate concentration than provided by either enzyme alone.
• the second enzyme may have an affinity for substrate that is at least about 2-fold greater than that of the first enzyme, for example, at least about 5-fold greater, or at least about 10-fold greater, or at least about 20-fold greater, or at least about 50-fold greater, or at least about 100-fold greater, or at least about 200-fold greater, or at least about 500-fold greater, or at least about 1000-fold greater, or more.
• the first enzyme may have a Km for substrate of about 1-100 ⁇ M, and the second enzyme may have a higher Km for substrate of about 30-300 ⁇ M; or the first enzyme may have a Km for substrate of about 1-100 ⁇ M, and the second enzyme may have a higher Km for substrate of about 50-500 ⁇ M.
• the first enzyme may have a Km for substrate of about 1-10 ⁇ M, and the second enzyme may have a higher Km for substrate of about 5-50 ⁇ M; or the first enzyme may have a Km for substrate of about 5-10 ⁇ M, and the second enzyme may have a higher Km for substrate of about 10-50 ⁇ M; or the first enzyme may have a Km for substrate of about 5-10 ⁇ M, and the second enzyme may have a higher Km for substrate of about 15-30 ⁇ M.
• Relevant Km values will depend on the particular enzyme and substrate of interest, and enzyme pairs having the differential Km values as described herein can be readily identified by one of skill in the art.
• the second enzyme may have a higher catalytic rate that is increased by at least about 2-fold greater than that of the first enzyme, for example, at least about 5 -fold greater, or at least about 10-fold greater, or at least about 20-fold greater, or at least about 50-fold greater, or at least about 100-fold greater, or at least about 200-fold greater, or at least about 500-fold greater, or at least about 1000-fold greater, or more.
• Relevant Kcat values will depend on the particular enzyme and substrate of interest, and enzyme pairs having the differential Kcat values as described herein can be readily identified by one of skill in the art.
• two or more polynucleotides encoding an EPSP synthase can be used to confer herbicide resistance across a broader range of substrate conditions than either EPSP alone.
• EPSP synthase is involved in the penultimate step in the shikimic acid pathway for the biosynthesis of aromatic amino acids and many secondary metabolites, including tetrahydrofolate, ubiquinone and vitamin K (Gruys et al. (1999) Inhibitors of Tryptophan, Phenyalanine, and Tyrosine Biosynthesis as Herbicides, Dekker, New York).
• EPSP synthase converts phosphoenolpyruvic acid (PEP) and 3-phosphoshikimic acid (S3P) to 5-enolpyruvyl-3- phosphoshikimic acid (Amrhein et al. (1980) Plant Physiol. 66:830-834).
• a two-component expression system can comprise a first EPSP enzyme with a substantially low Km for PEP ⁇ e.g., less than about 1 ⁇ M) and a high Ki for glyphosate ⁇ e.g., 200 ⁇ M), and a second EPSP enzyme with a more modest Km for PEP ⁇ e.g., about 40 ⁇ M) and a higher Ki for glyphosate ⁇ e.g., greater than about 2 mM). Plants that stably express polynucleotides encoding both EPSP synthases will show high levels of EPSP synthase activity over a broader spectrum of substrate concentration than provided by either enzyme alone.
• expression of two polynucleotides encoding a polypeptide of interest, wherein the first and second polypeptide have different Km and Kcat can result in an increase in enzyme activity of the polypeptide of interest over a range of substrate concentration that is at least about 2-fold greater than when either of the polynucleotides is expressed alone, for example at least about 5 -fold greater, or at least 10-fold greater, or at least about 25 -fold greater, or at least about 50-fold greater, or at least about 100-fold greater.
• the multiple-component expression system of the invention similarly provides for broadening of an effective range of enzyme activity limited by concentration of a cofactor, concentration of free radicals or free radical donors, concentration of an enzyme inhibitor or catalyst, or maximal catalytic rate.
• Enzyme activity can also be regulated by differential pH in plant parts, plant tissues, and plant cellular compartments.
• H /K + and/or H /Na + pumps maintain a higher pH in the chloroplast stroma (approximately pH 8.0) when compared to the cytoplasm (approximately pH 7.0 - 7.5). Alkalization of the chloroplast stroma is light-induced and allows for efficient function of photosynthetic carbon reduction cycle enzymes. See Wu et al.
• chloroplast e.g., the protein conferring atrazine resistance
• polypeptides conferring herbicide resistance are encoded in the chloroplast (e.g., the protein conferring atrazine resistance), or are encoded in the nuclear genome but function within chloroplasts (e.g., enol-pyruvylshikimate-phosphate synthase, which confers resistance to glyphosate) or mitochondria (e.g., aryl acylamidase, which confers resistance to propanil). See Della-Cioppa et al. (1986) Proc. Natl. Acad.
• the multi-enzyme expression system of the present invention provides improved enzyme activity over a broader range of temperature as compared to the individual enzymes of the combined expression system.
• the pH optima of the two or more enzymes of a multi-enzyme expression system can vary as described herein above with respect to fold or percentage differences of an environmental and/or physiological condition.
• a transgenic plant prepared as described herein may comprise a first polypeptide having optimal enzyme activity within a pH range of about pH 4.0 to about pH 6.5, and a second polypeptide having optimal enzyme activity at a higher pH as compared to the first polypeptide and within the range from about pH 6.0 to about pH 8.5.
• a representative plant having improved enzyme activity over a broader pH range may comprise a plant expressing a first polypeptide having an amino acid sequence of SEQ ID NO:4, and a second polypeptide having an amino acid of SEQ ID NO: 6. See Table I.
• Additional examples include a plant expressing a first polypeptide having optimal enzyme activity within a pH range of about pH 5.0 to about pH 5.5, and a second polypeptide having optimal enzyme activity at a higher pH as compared to the first polypeptide; a plant expressing a first polypeptide having optimal enzyme activity within a pH range of about pH 5.5 to about pH 6.0, and a second polypeptide having optimal enzyme activity at a higher pH as compared to the first polypeptide; a plant expressing a first polypeptide having optimal enzyme activity within a pH range of about pH 6.0 to about pH 6.5, and a second polypeptide having optimal enzyme activity at a higher pH as compared to the first polypeptide; a plant expressing a first polypeptide having optimal enzyme activity within a pH range of about pH 6.5 to about pH 7.0, and a second polypeptide having optimal enzyme activity at a higher pH as compared to the first polypeptide; a plant expressing a first polypeptide having optimal enzyme activity within a pH range of about pH
• Enzyme activity can also be strongly affected by salt concentration. It is known in the art that plant cells in different plant tissues are subject to large variations in salt concentration. These conditions can vary with environmental conditions. For example, stoma cells have widely varying intracellular salt levels depending on environmental conditions. Thus, the multi-enzyme expression methods of the invention are useful for generating plants with improved enzyme activity over a broader range of physiological salt concentrations than a single enzyme alone.
• transgenic plants of the invention may comprise a first polypeptide having optimal enzyme activity within a salt concentration range of about 50 mM to 150 mM, and a said second polypeptide having optimal enzyme activity at a higher salt concentration as compared to the first polypeptide and within a range from about 100 mM to 200 mM.
• a representative plant having improved enzyme activity over a broader pH range may comprise a plant expressing a first polypeptide having an amino acid sequence of SEQ ID NO:4, and a second polypeptide having an amino acid of SEQ ID NO: 6. See Table II and Figure 2. Additional examples include plants expressing a first polypeptide and a second polypeptide, wherein the second enzyme has optimal activity at a salt concentration that is at least about 2-fold greater than a salt concentration at which the first enzyme shows optimal activity, for example, at least about 5 -fold greater, or at least about 10-fold greater, or at least about 20-fold greater, or at least about 50-fold greater, or at least about 100-fold greater, or at least about 200-fold greater, or at least about 500- fold greater, or at least about 1000-fold greater.
• GS glutamine synthetase
• the methods disclosed in the instant application can be used to optimally express a first and second polynucleotide encoding first and second polypeptides having optimal activities in the different pH and/or salt environments of the chloroplast and cytoplasm, respectively.
• genes conferring traits of interest in chloroplasts, or in chloroplasts as well as cytoplasm is also useful in other instances, including for example, to improve production of essential amino acids in grains (see e.g., U.S. Patent Nos. 7,026,527 and 7,071,383); to regulate photosynthetic pathways, to regulate synthesis of lipids and plant growth regulatory hormones; to enhance a plant's ability to respond to stress conditions such as ultraviolet AB radiation, extreme temperatures, infection and/or high doses of irradiation; (see e.g., U.S. Patent No. 6,781,034); to modulate carbon allocation and starch synthesis (see e.g., U.S. Patent No. 6,716,474). See also Mullet, J. E. (1988) Ann. Rev. Plant Physiol. Plant MoI Biol. 39:475-502.
• a heterologous polypeptide which is optimized as disclosed herein for elevated activity in the alkaline environment of the chloroplast stroma, can further comprise a chloroplast transit peptide, as is known in the art. See e.g., U.S. Patent No. 6,130,366 and disclosure entitled “Polynucleotide Constructs" herein below.
• the polynucleotides encoding polypeptides of interest may be stably integrated into an organelle genome. For example, representative techniques for transforming chloroplasts are described in U.S. Patent No. 6,642,053.
• Polynucleotides expressed in plant organelles may also comprise promoters with specific and/or elevated expression in organelles, for example, as described in U.S. Patent Nos. 4,710,461 and 5,391,725. See also, disclosure entitled “Polynucleotide Constructs" herein below.
• compositions can be used to broaden the range of environmental and/or physiological conditions at which any enzyme of interest is active.
• desired traits include improved crop yield; insect resistance; tolerance to broad-spectrum herbicides; resistance to diseases caused by viruses, bacteria, fungi, and worms; and enhancement of mechanisms for protection from environmental stresses such as heat, cold, drought, and high salt concentration.
• Additional desired traits include output traits that benefit consumers, for example, nutritionally enhanced foods that contain more starch or protein, more vitamins, more anti-oxidants, and/or fewer trans-fatty acids; foods with improved taste, increased shelf-life, and better ripening characteristics; trees that make it possible to produce paper with less environmental damage; nicotine-free tobacco; ornamental flowers with new colors, fragrances, and increased longevity; etc.
• desirable traits include gene products produced in plants as a means for manufacturing, for example, therapeutic proteins for disease treatment and vaccination; textile fibers; biodegradable plastics; oils for use in paints, detergents, and lubricants; etc.
• Enzyme activity relevant to any of the above-noted traits, or any other desirable plant trait can be optimized by selection of multiple polynucleotides having different kinetic properties, as described herein.
• the polynucleotide of interest encodes a polypeptide capable of conferring herbicide resistance, i.e., an ability to tolerate a higher concentration of an herbicide, or to tolerate a certain concentration of an herbicide for a longer period of time than plants that are not tolerant or resistant to the herbicide.
• Techniques for measuring herbicide resistance activity are well known in the art. See e.g., U.S. Patent Nos. 4,535,060 and 5,188,642, each of which is herein incorporated by reference in their entirety.
• Herbicides for which several resistant or tolerant transgenes have been identified include, but are not limited to, the following:
• An herbicide of interest includes one that inhibits the growing point or meristem, such as an imidazolinone or a sulfonylurea.
• Exemplary polynucleotides that impart herbicide resistance to this class of herbicides include mutant ALS and AHAS enzymes as described, for example, by Lee et al. (1988) EMBO J. 7:1241, and Miki et al. (1990) Theor. Appl Genet. 80: 449, respectively. See also, U.S. Patent Nos.
• Additional herbicides of interest include glyphosate (resistance imparted by mutant 5- enolpyruvl-3-phosphikimate synthase (EPSP synthase) and aroA genes).
• glyphosate resistance imparted by mutant 5- enolpyruvl-3-phosphikimate synthase (EPSP synthase) and aroA genes.
• U.S. Patent No. 4,940,835 discloses the polynucleotide of a form of EPSP synthase which can confer glyphosate resistance.
• U.S. Patent No. 5,627,061 also describes genes encoding EPSP synthase enzymes. See also U.S. Patent. Nos.
• EPl 173582 each of which is incorporated herein by reference. Additional representative EPSP synthase polynucleotides are set forth as SEQ ID NOs: 1, 3, 5, and 7, which encode the EPSP synthase polypeptides of SEQ ID NOs: 2, 4, 6, and 8, respectively, and are also shown in Figures 5A-5P.
• Glyphosate resistance is also imparted to plants that express a gene encoding a glyphosate oxidoreductase enzyme as described more fully in U.S. Patent Nos. 5,776,760 and 5,463,175, which are incorporated herein by reference.
• glyphosate resistance can be imparted to plants by the over expression of polynucleotides encoding glyphosate N- acetyltransferase. See e.g., U.S. Patent Application Publication Nos. 20040082770 and PCT International Publication No. WO 01/46227.
• a DNA molecule encoding a mutant aroA gene, which also confers glyphosate resistance, can be obtained under American Type Culture Collection (ATCC) Accession No. 39256, and the polynucleotide of the mutant gene is disclosed in U.S. Patent No. 4,769,061.
• EPSP synthases have been isolated from plants, bacteria and fungi, including E. coli (Duncan et al. (1984) FEBS Lett. 170:59-63), Staphylococcus aureus (Horsburgh et al. (1996) Microbiology 142(Part 10):2943-2950), Streptococcus pneumoniae (Du et al. (2000) Eur. J. Biochem. 267(l):222-227) and Salmonella typhi (Chatf ⁇ eld et al. (1990) Nucleic Acids Res. 18(20):6133). EPSP synthase sequences have been characterized and residues frequently conserved in this class of polypeptides have been identified.
• Lys-22, Arg-124, Asp-313, Arg-344, Arg-386, and Lys-411 are conserved residues of the EPSP synthase from E. coli (Sch ⁇ nbrunn et al. (2001) Proc. Natl. Acad. Sci. U.S.A. 98:1376-1380). Additional residues that influence EPSP synthase activity also include Arg-100, Asp-242, and Asp-384 (Selvapandiyan et al. (1995) FEBS Letters 374:253-256). Arg-27 has been shown to bind to S3P (Shuttleworth et al. (1999) Biochemistry 38:296-302).
• EPSP synthase is the target of the herbicide glyphosate, i.e., any herbicidal form of N- phosphonomethylglycine (including any salt thereof) and active derivatives thereof that result in the production of the glyphosate anion inplanta.
• Inhibition of EPSP synthase by glyphosate has been shown to proceed through the formation of an EPSP synthase-S3P-glyphosate ternary complex and the binding is ordered with glyphosate binding to the enzyme only after the formation of a binary EPSP synthase-S3P complex.
• Glyphosate-resistant EPSP synthase polypeptides have been identified and used to increase glyphosate tolerance in plants.
• Glyphosate resistance polypeptides confer upon a cell an ability to tolerate a higher concentration of glyphosate than cells that do not express the polypeptide, or to tolerate a certain concentration of glyphosate for a longer time than cells that do not express the polypeptide.
• Tolerance refers to an ability to survive, or to carry out essential cellular functions such as protein synthesis and respiration in a manner that is not readily discernable from untreated cells.
• An example of a naturally-occurring glyphosate-resistant EPSP synthase includes the bacterial gene from Agrobacterium tumefacians strain CP4 which has been used to confer herbicide resistance on plant cells following expression in plants.
• Mutated EPSP synthase polypeptides have been identified through random mutagenesis and selection for herbicide resistance, including a mutated EPSP synthase from Salmonella typhimurium strain CT7 that confers glyphosate resistance in bacterial cells, and confers glyphosate resistance on plant cells (U.S. Patent Nos. 4,535,060; 4,769,061; and 5,094,945 and U.S. Appl. Nos. 60/669,686 and 20040177399).
• the present invention provides transgenic plants having two or more polypeptides conferring glyphosate resistance, for example, two or more glyphosate resistant EPSP synthase polypeptides, wherein the plants have an increased resistance to glyphosate and/or an increased yield over a broader range of environmental and/or physiological conditions than when only one of the polypeptides is expressed in the plant.
• plants expressing two or more EPSP synthase polypeptides have a broader temperature spectrum of resistance to glyphosate or increased yield of about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 20, or 25, 35, 45, 55, 65°C or greater than when either EPSP synthase polypeptides are expressed alone.
• plants expressing two or more EPSP synthase polypeptides wherein at least one of the two EPSP synthase polypeptides is active between about 0 0 C to about 10 0 C, about 10 0 C to about 20 0 C, about 20 0 C to about 30 0 C, about 30 0 C to about 40 0 C, about 40 0 C to about 50 0 C, about 50 0 C to about 60 0 C, or about 60 0 C to about 70 0 C.
• EPSP synthase activity can be assay by Lewendon et al. (1983) Biochem J. 213:187-91.
• Lewendon et al. (1983) Biochem J. 213:187-91 describes two assays which couple the EPSP synthase reaction with other enzymes which produced detectable products.
• EPSP synthase can be coupled with chorismate synthase, the enzyme in the shikimate acid pathway which converts EPSP to chorismate; as EPSP synthase produces EPSP, chorismate synthase can convert EPSP to chorismate which can be detected at 275 nm.
• EPSP synthase can also proceed in the reverse direction, activity can also be assayed with coupling to pyruvate kinase and lactate dehydrogenase which oxidize NADH in the breakdown of pyruvate, allowing the detection of NADH loss at 340 nm which corresponds to pyruvate evolution by EPSP synthase.
• EPSP synthase activity can also be assayed by measuring an increase in resistance of a plant to glyphosate when glyphosate-resistant EPSP synthase is present, or by measuring an increase in plant yield when glyphosate-sensitive and/or -tolerant EPSP synthase is expressed.
• EPSP synthase sequences derived from plants are also included in this invention.
• glyphosate-tolerant EPSP synthase enzymes derived from Brevundomonas vesicularis, Arthrobacter globifortnis , Enterobacteriaceae sp., and Sulfolobus solfataricus are enzymatically active at varying temperatures.
• Representative glyphosate resistant plants of the invention include plants expressing glyphosate-tolerant EPSP synthase polypeptides derived from at least Brevundomonas vesicularis and Arthrobacter globiformis; Brevundomonas vesicularis and Enterobacteriaceae sp.; Brevundomonas vesicularis and Sulfolobus solfataricus; Arthrobacter globiformis and Enterobacteriaceae sp.; Arthrobacter globiformis and Sulfolobus solfataricus; or Enterobacteriaceae sp. and Sulfolobus solfataricus .
• Additional plants of the invention express glyphosate-tolerant EPSP synthase polypeptides derived from at least Brevundomonas vesicularis, Arthrobacter globiformis, and Enterobacteriaceae sp.; Brevundomonas vesicularis, Enterobacteriaceae sp. and Sulfolobus solfataricus; Arthrobacter globiformis, Enterobacteriaceae sp., and Sulfolobus solfataricus; or Brevundomonas vesicularis, Arthrobacter globiformis, and Sulfolobus solfataricus .
• Still additional plants of the inventions express glyphosate tolerant EPSP synthase polypeptides derived from at least Brevundomonas vesicularis, Arthrobacter globiformis, Enterobacteriaceae sp., and Sulfolobus solfataricus . It is contemplated that other glyphosate-tolerant EPSP synthase polypeptides can be used in the present invention in addition to those described above, or in any combination with any number of the polypeptides described above such that EPSP synthase is active across a broader range of environmental and/or physiological conditions than expression of either EPSP synthase polypeptide alone.
• EPSP synthase enzymes As discussed in further detail herein below, variants of any known EPSP synthase enzymes or those disclosed herein can be employed in the methods and compositions of the invention. Functional variants of EPSP synthase which are tolerant to glyphosate are known. See e.g., Kishore and Shah (1988) Ann. Rev. Biochem. 57:627-63; Wang et al. (2003) J. Plant Res. 116:455-60; and Eschenburg et al. (2002) Planta 216:129-35.
• nitrilase gene An herbicide that inhibits photosynthesis, such as a triazine (psbA and gs+genes) and a benzonitrile (nitrilase gene) is also of interest.
• Przibilla et al. (1991) Plant Cell 3:169 describes the transformation of Chlamydomonas with plasmids encoding mutant psbA genes.
• Polynucleotides for nitrilase genes are disclosed in U.S. Patent No. 4,810,648 and DNA molecules containing these genes are available under ATCC Accession Nos. 53435, 67441, and 67442. Cloning and expression of DNA coding for a glutathione S-transferase is described by Hayes et al. (1992) Biochem. J. 285:173.
• Protoporphyrinogen oxidase is necessary for the production of chlorophyll, which is necessary for all plant survival.
• the protox enzyme serves as the target for a variety of herbicidal compounds. These herbicides also inhibit growth of all the different species of plants present, causing their total destruction. The development of plants containing altered protox activity which are resistant to these herbicides are described in U.S. Patent Nos. 6,084,155; 6,288,306; 6,282,837; and 5,767,373; and PCT International Publication No. WO 01/12825.
• Additional herbicides of interest include phosphono compounds such as glufosinate (resistance provided by phosphinothricin acetyl transferase (PAT) and Streptomyces hygroscopicus phosphinothricin acetyl transferase (bar) genes).
• PAT phosphinothricin acetyl transferase
• bar Streptomyces hygroscopicus phosphinothricin acetyl transferase
• European Patent Application Publication No. 0333033A and U.S. Patent No. 4,975,374 disclose polynucleotides of glutamine synthetase genes which confer resistance to herbicides such as L-phosphinothricin.
• the polynucleotide of a phosphinothricin acetyl transferase gene is provided in European Patent Nos.
• Additional herbicides are pyridinoxy or phenoxy proprionic acids and cycloshexones (resistance conferred by ACCase inhibitor-encoding genes).
• exemplary polynucleotides conferring resistance to phenoxy proprionic acids and cycloshexones, such as sethoxydim and haloxyfop are the Ace 1 -Sl, Accl-S2 and Ace 1 -S3 genes described by Marshall et al. (1992) Theor. Appl. Genet. 83: 435.
• the present invention further contemplates variants and fragments of the herbicide resistance polynucleotides and polypeptides described herein.
• Various methods can be employed to modify the various polypeptides which confer resistance to an herbicide such that the new polypeptide will have the desired activity at a different temperature optimum. For example, gene shuffling or sexual PCR procedures (for example, Smith (1994) Nature 370:324-25; U.S. Patent Nos.
• DNA segments isolated from a pool of positive mutants are cleaved into random fragments with DNaseI and subjected to multiple rounds of PCR with no added primer.
• the lengths of random fragments approach that of the uncleaved segment as the PCR cycles proceed, resulting in mutations in different clones becoming mixed and accumulating in some of the resulting sequences.
• Multiple cycles of selection and shuffling have led to the functional enhancement of several enzymes (Stemmer (1994) Nature 370:398-91; Stemmer (1994) Proc. Natl Acad. Sci. USA 91 :10747-51; Crameri et al. (1996) Nat. Biotechnol. 14:315-19; Zhang et al.
• Fragments or biologically active portions include polypeptide fragments comprising a portion of an amino acid sequence encoding a polypeptide and that retains biological activity (i.e., herbicide resistance or EPSP synthase activity such as increased yield and/or resistance to glyphosate).
• a fragment of a polynucleotide may encode a biologically active portion of a polypeptide, or it may be a fragment that can be used as a hybridization probe or PCR primer using methods disclosed elsewhere herein.
• Polynucleotides that are fragments of a polynucleotide comprise at least about 15, 20, 50, 75, 100, 200, 300, 350, 400, 450, 500, 550, 600, 650, 700, 750, 800, 850, 900, 950, 1000, 1050, 1100, 1150, 1200, 1250, 1300, 1350, 1400, 1450, 1500, 1550, 1600, 1650, 1700, 1750, 1800, 1850, 1900, 1950 contiguous nucleotides, or up to the number of nucleotides present in a full-length polynucleotide disclosed herein depending upon the intended use. Contiguous nucleotides are immediately adjacent to one another.
• Fragments of a polynucleotide can encode polypeptide fragments that retain the biological activity of the full-length polypeptide (e.g., herbicide resistance or EPSP synthase activity such as increased yield and/or resistance to glyphosate).
• a fragment retains a biological activity of the full-length polypeptide if it has at least about 30%, at least about 50%, at least about 70%, or at least about 80% of the activity of the full-length polypeptide.
• a fragment of a polynucleotide that encodes a biologically active portion of a polypeptide of the invention can encode at least about 15, 25, 30, 50, 75, 100, 125, 150, 175, 200, 250, 300, 350, 400 contiguous amino acids, or up to the total number of amino acids present in a full-length polypeptide of the invention.
• variants of the EPSP synthase polypeptides disclosed herein include polypeptides that differ conservatively because of the degeneracy of the genetic code, as well as those that are sufficiently identical.
• Sufficiently identical polypeptides refer to polypeptides having an amino acid sequence that has at least about 60% or 65% sequence identity, about 70% or 75% sequence identity, about 80% or 85% sequence identity, about 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or 99% sequence identity compared to a reference sequence using one of the alignment programs using standard parameters.
• the sequences are aligned for optimal comparison purposes.
• the two sequences may be the same length.
• the percent identity between two sequences can be determined using techniques similar to those described below, with or without allowing gaps. In calculating percent identity, typically exact matches are counted.
• the determination of percent identity between two sequences can be accomplished using a mathematical algorithm.
• a nonlimiting example of a mathematical algorithm utilized for the comparison of two sequences is the algorithm of Karlin and Altschul (1990) Proc. Natl. Acad. ScL USA 87:2264, modified as in Karlin and Altschul (1993) Proc. Natl. Acad. ScL USA 90:5873-5877. Such an algorithm is incorporated into the BLASTN and BLASTX programs of Altschul et al. (1990) J. MoI. Biol. 215:403.
• Gapped BLAST can be utilized as described in Altschul et al. (1997) Nucleic Acids Res. 25:3389.
• PSI-Blast can be used to perform an iterated search that detects distant relationships between molecules. See Altschul et al. (1997) supra.
• the ClustalW algorithm is used in several commercially available DNA/amino acid analysis software packages, such as the ALIGNX module of the vector NTi Program Suite (Informax, Inc). After alignment of amino acid sequences with ClustalW, the percent amino acid identity can be assessed.
• a non-limiting example of a software program useful for analysis of ClustalW alignments is GENEDOCTM.
• GENEDOCTM (Karl Nicholas) allows assessment of amino acid (or DNA) similarity and identity between multiple polypeptides.
• Another non-limiting example of a mathematical algorithm utilized for the comparison of sequences is the algorithm of Myers and Miller (1988) CABIOS 4:11-17. Such an algorithm is incorporated into the ALIGN program (version 2.0), which is part of the GCG sequence alignment software package.
• a PAM 120 weight residue table, a gap length penalty of 12, and a gap penalty of 4 can be used.
• GAP Version 10 which uses the algorithm of Needleman and Wunsch (1970) supra, will be used to determine sequence identity or similarity using the following parameters: % identity and % similarity for a nucleotide sequence using GAP Weight of 50 and Length Weight of 3, and the nwsgapdna.cmp scoring matrix; % identity or % similarity for an amino acid sequence using GAP weight of 8 and length weight of 2, and the BLOSUM62 scoring program. Equivalent programs may also be used, including any sequence comparison program that, for any two sequences in question, generates an alignment having identical nucleotide residue matches and an identical percent sequence identity when compared to the corresponding alignment generated by GAP Version 10.
• Naturally occurring polynucleotide variants can be identified using well-known molecular biology techniques, such as polymerase chain reaction (PCR) and hybridization techniques as outlined below.
• Variant polynucleotides also include synthetically derived polynucleotides that have been generated, for example, by using site-directed mutagenesis but which still encode the polypeptide having the desired biological activity.
• Variant polypeptides encompassed by the present invention are biologically active, that is they retain the desired biological activity of the native polypeptide, i.e., herbicide resistance activity or EPSP synthase activity such as increased yield and/or resistance glyphosate.
• Bioly active variants have at least about 30% of the activity of the native polypeptide, for example, at least about 50%, or at least about 70%, or at least about 80%, or at least about 90%, or at least about 95%. Methods for measuring enzyme activity are specific to individual enzymes of interest.
• variant isolated polynucleotides can be created by introducing one or more nucleotide substitutions, additions, or deletions into the corresponding polynucleotide disclosed herein, such that one or more amino acid substitutions, additions or deletions are introduced into the encoded polypeptide. Mutations can be introduced by standard techniques, such as site-directed mutagenesis and PCR-mediated mutagenesis, or shuffling techniques, which are described in further detail elsewhere herein. Such variant polynucleotides are also encompassed by the present invention.
• conservative amino acid substitutions may be made at one or more nonessential amino acid residues, i.e., a residue that can be altered from the native sequence of a polypeptide without altering the biological activity.
• an essential amino acid residue is required for biological activity.
• a conservative amino acid substitution is one in which the amino acid residue is replaced with an amino acid residue having a similar side chain. Families of amino acid residues having similar side chains have been defined in the art.
• amino acids with basic side chains e.g., lysine, arginine, histidine
• acidic side chains e.g., aspartic acid, glutamic acid
• uncharged polar side chains e.g., glycine, asparagine, glutamine, serine, threonine, tyrosine, cysteine
• nonpolar side chains e.g., alanine, valine, leucine, isoleucine, proline, phenylalanine, methionine, tryptophan
• beta-branched side chains e.g., threonine, valine, isoleucine
• aromatic side chains e.g., tyrosine, phenylalanine, tryptophan, histidine
• Amino acid substitutions may be made in nonconserved regions that retain function. In general, such substitutions would not be made for conserved amino acid residues, or for amino acid residues residing within a conserved motif, where such residues are essential for polypeptide activity. However, one of skill in the art would understand that functional variants may have minor conserved or nonconserved alterations in the conserved residues.
• variant polynucleotides can be made by introducing mutations randomly along all or part of the coding sequence, such as by saturation mutagenesis, and the resultant mutants can be screened for the ability to confer herbicide resistance activity to identify mutants that retain activity.
• the encoded polypeptide can be expressed recombinantly, and the activity of the polypeptide can be determined using standard assay techniques.
• the polynucleotides employed in the methods and compositions of the invention may be modified to obtain or enhance expression in plant cells.
• the polynucleotides of the invention may be provided in expression cassettes for expression in the plant of interest.
• Plant expression cassettes include a DNA construct that is capable of resulting in the expression of a polynucleotide in a plant cell.
• the cassette can include in the 5 '-3' direction of transcription, a transcriptional initiation region (i.e., promoter) operably linked to one or more polynucleotides of interest, and a translation and transcriptional termination region (i.e., termination region) functional in plants.
• the cassette may additionally contain at least one additional polynucleotide to be introduced into the organism, such as a selectable marker gene or the second polynucleotide of interest with different temperature optima for activity.
• the additional polynucleotide(s) can be provided on multiple expression cassettes.
• Such an expression cassette is provided with a plurality of restriction sites for insertion of the polynucleotide(s) to be under the transcriptional regulation of the regulatory regions.
• a heterologous polynucleotide or polypeptide is one that is not endogenous to the cell or is not endogenous to the location in the native genome in which it is present, and has been added to the cell by infection, transfection, microinjection, electroporation, microprojection, or the like.
• a heterologous polynucleotide such polynucleotide is operably linked to a promoter sequence that initiates and mediates its transcription. It is recognized that operably linked polynucleotides may or may not be contiguous. Where used to reference the joining of two polypeptide coding regions, operably linked polypeptides are expressed in the same reading frame.
• the promoter may be any polynucleotide sequence which shows transcriptional activity in the chosen plant cells, plant parts, or plants.
• the promoter may be native or analogous, or foreign or heterologous, to the plant host and/or to the DNA sequence of the invention. Where the promoter is native or endogenous to the plant host, it is intended that the promoter is found in the native plant into which the promoter is introduced. Where the promoter is foreign or heterologous to the DNA sequence of the invention, the promoter is not the native or naturally occurring promoter for the operably linked DNA sequence of the invention.
• the promoter may be inducible or constitutive. It may be naturally-occurring, may be composed of portions of various naturally-occurring promoters, or may be partially or totally synthetic.
• suitable constitutive promoters for use in plants include: the promoters from plant viruses, such as the peanut chlorotic streak caulimovirus (PClSV) promoter (U.S. Patent No. 5,850,019); the 35S promoter from cauliflower mosaic virus (CaMV) (Odell et al. (1985) Nature 313:810-812); promoters of Chlorella virus methyltransferase genes (U.S. Patent No. 5,563,328) and the full-length transcript promoter from figwort mosaic virus (FMV) (U.S. Patent No. 5,378,619); the promoters from such genes as rice actin (McElroy et al.
• PClSV peanut chlorotic streak caulimovirus
• CaMV cauliflower mosaic virus
• FMV figwort mosaic virus
• Suitable inducible promoters for use in plants include: the promoter from the ACEl system which responds to copper (Mett et al. (1993) Proc. Natl. Acad. Sci. USA 90:4567-4571); the promoter of the maize In2 gene which responds to benzenesulfonamide herbicide safeners (Hershey et al. (1991) MoI. Gen. Genetics 227:229-237 and Gatz et al. (1994) MoI. Gen. Genetics 243:32-38); and the promoter of the Tet repressor from TnIO (Gatz et al, (1991) MoI. Gen. Genet. 227:229-237).
• Another inducible promoter for use in plants is one that responds to an inducing agent to which plants do not normally respond.
• An exemplary inducible promoter of this type is the inducible promoter from a steroid hormone gene, the transcriptional activity of which is induced by a glucocorticosteroid hormone (Schena et al. (1991) Proc. Natl. Acad. Sci. USA 88:10421) or the recent application of a chimeric transcription activator, XVE, for use in an estrogen receptor-based inducible plant expression system activated by estradiol (Zuo et al. (2000) Plant J, 24:265-273).
• inducible promoters for use in plants are described in EP 332104, PCT International Publication Nos. WO 93/21334 and WO 97/06269. Promoters composed of portions of other promoters and partially or totally synthetic promoters can also be used. See e.g., Ni et al. (1995) Plant J. 7:661-676 and PCT International Publication No. WO 95/14098 describing such promoters for use in plants.
• the promoter may include, or be modified to include, one or more enhancer elements. Promoters containing enhancer elements provide for higher levels of transcription as compared to promoters that do not include them. Suitable enhancer elements for use in plants include the PClSV enhancer element (U.S. Patent No. 5,850,019), the CaMV 35S enhancer element (U.S. Patent Nos. 5,106,739 and 5,164,316) and the FMV enhancer element (Maiti et al. (1997) Transgenic Res. 6:143-156). See also PCT International Publication No. WO 96/23898.
• constructs can contain 5' and 3' untranslated regions.
• Such constructs may contain a 'signal sequence' or 'leader sequence' to facilitate co-translational or post-translational transport of the peptide of interest to certain intracellular structures such as the chloroplast (or other plastid), endoplasmic reticulum, or Golgi apparatus, or to be secreted.
• the construct can be engineered to contain a signal peptide to facilitate transfer of the peptide to the endoplasmic reticulum.
• a signal sequence is known or suspected to result in cotranslational or post-translational peptide transport across the cell membrane.
• leader sequence refers to any sequence that, when translated, results in an amino acid sequence sufficient to trigger co-translational transport of the peptide chain to a sub-cellular organelle.
• this includes leader sequences targeting transport and/or glycosylation by passage into the endoplasmic reticulum, passage to vacuoles, plastids including chloroplasts, mitochondria, and the like.
• Plant expression cassettes may also contain an intron, such that mRNA processing of the intron is required for expression.
• a 3' untranslated region is a polynucleotide located downstream of a coding sequence.
• Polyadenylation signal sequences and other sequences encoding regulatory signals capable of affecting the addition of polyadenylic acid tracts to the 3' end of the mRNA precursor are 3' untranslated regions.
• a 5' untranslated region is a polynucleotide located upstream of a coding sequence.
• Enhancers are polynucleotides that act to increase the expression of a promoter region. Enhancers are well known in the art and include, but are not limited to, the SV40 enhancer region and the 35S enhancer element.
• the termination region may be native with the transcriptional initiation region, may be native with the sequence of the present invention, or may be derived from another source.
• Convenient termination regions are available from the Ti-plasmid of A. tumefaciens, such as the octopine synthase and nopaline synthase termination regions. See also Guerineau et al. (1991) MoI. Gen. Genet. 262:141-144; Proudfoot (1991) Cell 64:671-674; Sanfacon et al. (1991) Genes Dev. 5:141-149; Mogen et al. (1990) Plant Cell 2:1261-1272; Munroe et al.
• the polynucleotide(s) may be optimized for increased expression in the transformed host cell. That is, the sequences can be synthesized using host cell-preferred codons for improved expression, or may be synthesized using codons at a host-preferred codon usage frequency. Generally, the GC content of the polynucleotide will be increased. See e.g., Campbell and Gowri (1990) Plant Physiol. 92:1-11 for a discussion of host-preferred codon usage. Methods are known in the art for synthesizing host-preferred polynucleotides. See e.g., U.S. Patent Nos.
• polynucleotides of interest are targeted to the chloroplast for expression.
• the expression cassette may additionally contain a polynucleotide encoding a transit peptide to direct the nucleotide of interest to the chloroplasts.
• transit peptides are known in the art. See e.g., Von Heijne et al. (1991) Plant MoI. Biol. Rep. 9:104-126; Clark et al. (1989) J. Biol. Chem. 264:17544-17550; Della-Cioppa et al. (1987) Plant Physiol. 84:965-968; Romer et al. (1993) Biochem. Biophys. Res. Commun. 196:1414-1421; and Shah et al. (1986) Science 233:478-481.
• the polynucleotides of interest to be targeted to the chloroplast may be optimized for expression in the chloroplast to account for differences in codon usage between the plant nucleus and this organelle. In this manner, the polynucleotides of interest may be synthesized using chloroplast-preferred codons. See e.g., U.S. Patent No. 5,380,831, herein incorporated by reference.
• This plant expression cassette can be inserted into a plant transformation vector, which allows for the transformation of DNA into a cell.
• a plant transformation vector which allows for the transformation of DNA into a cell.
• Such a molecule may consist of one or more expression cassettes, and may be organized into more than one vector DNA molecule.
• binary vectors are plant transformation vectors that utilize two non-contiguous DNA vectors to encode all requisite cis- and trans-acting functions for transformation of plant cells (Hellens and Mullineaux (2000) Trends in Plant Science 5:446-451).
• Vectors are polynucleotide constructs designed for transfer between different host cells.
• Expression vectors are a type of vector having an ability to incorporate, integrate and express heterologous DNA sequences or fragments in a foreign cell.
• the plant transformation vector comprises one or more DNA vectors for achieving plant transformation.
• DNA vectors for achieving plant transformation.
• These vectors are often referred to in the art as binary vectors.
• Binary vectors as well as vectors with helper plasmids are most often used for Agrobacterium-mQdiatQd transformation, where the size and complexity of DNA segments needed to achieve efficient transformation is quite large, and it is advantageous to separate functions onto separate DNA molecules.
• Binary vectors typically contain a plasmid vector that contains the cis-acting sequences required for T-DNA transfer (such as left border and right border), a selectable marker that is engineered to be capable of expression in a plant cell, and a polynucleotide of interest (i.e., a polynucleotide engineered to be capable of expression in a plant cell for which generation of transgenic plants is desired). Also present on this plasmid vector are sequences required for bacterial replication. The cis-acting sequences are arranged in a fashion to allow efficient transfer into plant cells and expression therein. For example, the selectable marker sequence and the sequence of interest are located between the left and right borders.
• a second plasmid vector contains the trans-acting factors that mediate T- DNA transfer from Agrobacterium to plant cells.
• This plasmid often contains the virulence functions (Vir genes) that allow infection of plant cells by Agrobacterium, and transfer of DNA by cleavage at border sequences and vir-mediated DNA transfer, as in understood in the art (Hellens and Mullineaux (2000) Trends in Plant Science, 5:446-451).
• Several types of Agrobacterium strains e.g., LBA4404, GV3101, EHAlOl, EHA105, etc.
• the second plasmid vector is not necessary for introduction of polynucleotides into plants by other methods such as microprojection, microinjection, electroporation, polyethylene glycol, etc.
• the present invention further provides transgenic plants comprising more than one of the polynucleotides of the invention to elevate the activity of the desired enzyme over a broad temperature spectrum.
• transgenic plants comprising more than one of the polynucleotides of the invention to elevate the activity of the desired enzyme over a broad temperature spectrum.
• the first polynucleotide is positioned in the plant vector directly downstream of at least the second polynucleotide under the direction of a single promoter.
• the first and at least the second polynucleotides can be separated and put under the direction of different promoters within a single construct.
• both the first and at least the second polynucleotides are placed under the control of separate promoters, in a single plasmid construct. This enables the expression of each polynucleotide as a separate entity; however, the tandem would behave in the plant progeny as a single locus.
• the maize streak virus promoter is a bi- functional promoter able to express genes in two directions. Using this promoter, transcription can be initiated on opposite strands in the vector and in opposite directions. Therefore, each polynucleotide can be expressed from a single promoter.
• Two or more polynucleotides Two or more constructs.
• two or more separate vector constructs are made, each containing one of the polynucleotides under the direction of different promoters. This approach requires that the plant be doubly transformed.
• Cells modified according to the present invention are contemplated at each stage of the invention.
• This invention further contemplates the introduction of at least one polynucleotide whose enzyme activity is optimal within a temperature range that extends beyond that of the native enzyme and thereby broadens the temperature range in which the enzyme is active in the cell.
• Host cells are useful for making, storing, reproducing or manipulating polynucleotide constructs of the invention.
• Contemplated host cells are eukaryotic cells, such as yeast or plant cells.
• Prokaryotic host cells containing constructs and/or vectors according to the invention are also contemplated ⁇ i.e., E. col ⁇ ).
• LD Plants and Plant Parts
• a plant refers to a whole plant, a plant organ (e.g., leaves, stems, roots, etc.), a seed, a plant cell, a propagule, an embryo, and progeny of the same.
• Plant cells can be differentiated or undifferentiated (e.g., callus, suspension culture cells, protoplasts, leaf cells, root cells, phloem cells, pollen).
• the present invention may be used for introduction of polynucleotides into any plant species, including, but not limited to, monocots and dicots.
• plants of interest include, but are not limited to, corn (maize), sorghum, wheat, sunflower, tomato, crucifers, peppers, potato, cotton, rice, soybean, sugarbeet, sugarcane, tobacco, barley, and oilseed rape, Brassica sp., alfalfa, rye, millet, safflower, peanuts, sweet potato, cassava, coffee, coconut, pineapple, citrus trees, cocoa, tea, banana, avocado, fig, guava, mango, olive, papaya, cashew, macadamia, almond, oats, vegetables, ornamentals, and conifers.
• Vegetables include, but are not limited to, tomatoes, lettuce, green beans, lima beans, peas, and members of the genus Curcumis such as cucumber, cantaloupe, and musk melon. Ornamentals include, but are not limited to, azalea, hydrangea, hibiscus, roses, tulips, daffodils, petunias, carnation, poinsettia , and chrysanthemum. Crop plants are also of interest, including, for example, maize, sorghum, wheat, sunflower, tomato, crucifers, peppers, potato, cotton, rice, soybean, sugarbeet, sugarcane, tobacco, barley, oilseed rape, etc.
• This invention is suitable for any member of the monocot plant family including, but not limited to, maize, rice, barley, oats, wheat, sorghum, rye, sugarcane, pineapple, yams, onion, banana, coconut, and dates.
• the present invention provides methods of conferring a trait of interest to a plant by introducing into a plant at least (a) a first heterologous polynucleotide encoding a first polypeptide capable of conferring said trait of interest, and (b) a second heterologous polynucleotide encoding a second polypeptide capable of conferring said trait of interest, wherein said first and second polynucleotides are stably expressed in said plant, and wherein said plant shows said trait of interest over a broader spectrum of a physiological or environmental condition as compared to a plant comprising either said first or second polynucleotide expressed alone and subject to said spectrum of a physiological or environmental condition.
• a second heterologous polynucleotide is introduced into a plant that already harbors a first heterologous polynucleotide.
• a method of conferring a trait of interest can also comprise (a) providing a transgenic plant comprising a first heterologous polynucleotide encoding a first polypeptide capable of conferring said trait of interest, and (b) introducing into said plant at least a second heterologous polynucleotide encoding a second polypeptide capable of conferring said trait of interest, wherein said first and second polynucleotides are stably expressed in said plant, and wherein said plant shows said trait of interest over a broader spectrum of a physiological or environmental condition as compared to a plant comprising either said first or second polynucleotide expressed alone and subject to said spectrum of a physiological or environmental condition.
• Relevant traits of interest are described herein above, including for example, herbicide resistance and plant yield.
• At least two polynucleotides encoding polypeptides that confer resistance to an herbicide of interest are introduced into a plant, wherein expression of the at least two polynucleotides increases enzyme activity over a broader spectrum of temperatures than expression of either polynucleotide alone.
• various polynucleotides can be employed in this method including, but not limited to, EPSP synthase sequences that can confer resistance to glyphosate.
• the disclosed methods can also be used to improve plant yield, i.e., the quality and/or quantity of biomass produced by the plant.
• Biomass is a measurable amount or weight of a plant product.
• An increase in biomass production is any improvement in the yield of the measured plant product.
• Increasing plant yield has several commercial applications. For example, increasing plant leaf biomass may increase the yield of leafy vegetables for human or animal consumption. Additionally, increasing leaf biomass can be used to increase production of plant- derived pharmaceutical or industrial products.
• An increase in yield can comprise any statistically significant increase including, but not limited to, at least a 1% increase, at least a 3% increase, at least a 5% increase, at least a 10% increase, at least a 20% increase, at least a 30%, at least a 50%, at least a 70%, at least a 100% or a greater increase.
• Plants produced using the disclosed methods can be treated with an effective concentration of an herbicide, where the herbicide application results in enhanced plant yield.
• An effective concentration is a concentration which allows the increased yield in the plant.
• Such effective concentrations for herbicides of interest are generally known in the art.
• the herbicide may be applied either pre- or post emergence in accordance with usual techniques for herbicide application to fields comprising crops which have been rendered resistant to the herbicide.
• Methods of the invention involve introducing one or more polynucleotides into a plant by presenting to the plant the polynucleotide in such a manner that the polynucleotide gains access to the interior of a cell of the plant.
• the methods of the invention do not require that a particular method for introducing a polynucleotide into a plant is used, only that the polynucleotide gains access to the interior of at least one cell of the plant.
• a polynucleotide into plant cells is accomplished by one of several techniques known in the art, including but not limited to electroporation or chemical transformation (See e.g., Ausubel, ed. (1994) Current Protocols in Molecular Biology, John Wiley and Sons, Inc., Indianapolis, Indiana. Markers conferring resistance to toxic substances are useful in identifying transformed cells (having taken up and expressed the test polynucleotide sequence) from non-transformed cells (those not containing or not expressing the test polynucleotide sequence). In one aspect of the invention, genes are useful as a marker to assess introduction of DNA into plant cells.
• Transgenic plants, transformed plants, or stably transformed plants, or cells, tissues or seed of any of the foregoing, refer to plants that have incorporated or integrated exogenous polynucleotides into the plant cell.
• Stable transformation refers to introduction of a polynucleotide construct a plant such that it integrates into the genome of the plant and is capable of being inherited by progeny thereof.
• plant transformation methods involve transferring heterologous DNA into target plant cells (e.g., immature or mature embryos, suspension cultures, undifferentiated callus, protoplasts, etc.), followed by applying a maximum threshold level of appropriate selection (depending on the selectable marker gene) to recover the transformed plant cells from a group of untransformed cell mass.
• target plant cells e.g., immature or mature embryos, suspension cultures, undifferentiated callus, protoplasts, etc.
• a maximum threshold level of appropriate selection depending on the selectable marker gene
• Explants are typically transferred to a fresh supply of the same medium and cultured routinely.
• the transformed cells are differentiated into shoots after placing on regeneration medium supplemented with a maximum threshold level of selecting agent (i.e., temperature and/or herbicide).
• the shoots are then transferred to a selective rooting medium for recovering rooted shoot or plantlet.
• the transgenic plantlet then grow into mature plant and produce fertile seeds (e.g., Hiei et al. (1994) Plant J. 6:271-282; Ishida et al. (1996) Nat. Biotechnol. 14:745-750).
• a general description of the techniques and methods for generating transgenic plants are found in Ayres and Park (1994) CRC Crit. Rev. Plant Sci. 13:219-239, and Bommineni and Jauhar (1997) Maydica 42:107-120. Since the transformed material contains many cells, both transformed and non-transformed cells are present in any piece of subjected target callus or tissue or group of cells. The ability to kill non-transformed cells and allow transformed cells to proliferate results in transformed plant cultures.
• Transgenic plants may be performed by one of several methods, including but not limited to introduction of heterologous DNA by Agrobacterium into plant cells (Agrobacterium -mediated transformation), bombardment of plant cells with heterologous foreign DNA adhered to particles, and various other non-particle direct-mediated methods (e.g., Hiei et al. (1994) Plant J. 6:271-282; Ishida et al. (1996) Nat. Biotechnol. 14:745-750; Ayres and Park (1994) CRC Crit. Rev. Plant Sci. 13:219-239; Bommineni and Jauhar (1997) Maydica 42:107- 120) to transfer DNA.
• Agrobacterium -mediated transformation introduction of heterologous DNA by Agrobacterium into plant cells
• bombardment of plant cells with heterologous foreign DNA adhered to particles and various other non-particle direct-mediated methods (e.g., Hiei et al. (1994) Plant J. 6:271-282; Ishida et al.
• the first method is co-cultivation of Agrobacterium with cultured isolated protoplasts. This method requires an established culture system that allows culturing protoplasts and plant regeneration from cultured protoplasts.
• the second method is transformation of cells or tissues with Agrobacterium. This method requires (a) that the plant cells or tissues can be transformed by Agrobacterium and (b) that the transformed cells or tissues can be induced to regenerate into whole plants.
• the third method is transformation of seeds, apices or meristems with Agrobacterium. This method requires micropropagation.
• the efficiency of transformation by Agrobacterium may be enhanced by using a number of methods known in the art. For example, the inclusion of a natural wound response molecule such as acetosyringone (AS) to the Agrobacterium culture has been shown to enhance transformation efficiency with Agrobacterium tumefaciens (Shahla et al. (1987) Plant Molec. Biol. 8:291-298). Alternatively, transformation efficiency may be enhanced by wounding the target tissue to be transformed. Wounding of plant tissue may be achieved, for example, by punching, maceration, bombardment with microprojectiles, etc. See e.g., Bidney et al. (1992) Plant Molec. Biol. 18:301-313.
• the plant cells are transfected with vectors via particle bombardment (i.e., with a gene gun).
• particle bombardment i.e., with a gene gun.
• Particle mediated gene transfer methods are known in the art, are commercially available, and include, but are not limited to, the gas driven gene delivery instrument described in McCabe, U.S. Patent No. 5,584,807, the entire contents of which are herein incorporated by reference. This method involves coating the polynucleotide sequence of interest onto heavy metal particles, and accelerating the coated particles under the pressure of compressed gas for delivery to the target tissue.
• Other particle bombardment methods are also available for the introduction of heterologous polynucleotide sequences into plant cells.
• these methods involve depositing the polynucleotide sequence of interest upon the surface of small, dense particles of a material such as gold, platinum, or tungsten.
• the coated particles are themselves then coated onto either a rigid surface, such as a metal plate, or onto a carrier sheet made of a fragile material such as mylar.
• the coated sheet is then accelerated toward the target biological tissue.
• the use of the flat sheet generates a uniform spread of accelerated particles that maximizes the number of cells receiving particles under uniform conditions, resulting in the introduction of the polynucleotide sample into the target tissue.
• Specific initiation signals may also be used to achieve more efficient translation of sequences encoding the polypeptide of interest. Such signals include the ATG initiation codon and adjacent sequences. In cases where sequences encoding the polypeptide of interest, its initiation codon, and upstream sequences are inserted into the appropriate expression vector, no additional transcriptional or translational control signals may be needed. However, in cases where only coding sequence, or a portion thereof, is inserted, exogenous translational control signals including the ATG initiation codon should be provided. Furthermore, the initiation codon should be in the correct reading frame to ensure translation of the entire insert. Exogenous translational elements and initiation codons may be of various origins, both natural and synthetic. The efficiency of expression may be enhanced by the inclusion of enhancers that are appropriate for the particular cell system that is used, such as those described in the literature (Scharf et al. (1994) Results Probl. Cell Differ. 20:125).
• the cells that have been transformed may be grown into plants in accordance with conventional ways. See e.g., McCormick et al. (1986) Plant Cell Rep. 5:81-84. These plants may then be grown, and either pollinated with the same transformed strain or different strains, and the resulting hybrid having constitutive expression of the desired phenotypic characteristic identified. Two or more generations may be grown to ensure that expression of the desired phenotypic characteristic is stably maintained and inherited and then seeds harvested to ensure expression of the desired phenotypic characteristic has been achieved. In this manner, the present invention provides transformed seed (also referred to as transgenic seed) having a polynucleotide of the invention, for example, an expression cassette of the invention, stably incorporated into their genome.
• Transgenic plants of the invention can be homozygous for the added polynucleotides; i.e., a transgenic plant that contains two added sequences, one sequence at the same locus on each chromosome of a chromosome pair.
• a homozygous transgenic plant can be obtained by sexually mating (selfing) an independent segregant transgenic plant that contains the added sequences according to the invention, germinating some of the seed produced and analyzing the resulting plants produced for enhanced enzyme activity (i.e., herbicide resistance) and/or increased plant yield relative to a control (native, non-transgenic) or an independent segregant transgenic plant.
• transgenic plants can also be mated to produce offspring that contain two independently segregating added, exogenous polynucleotides. Selfing of appropriate progeny can produce plants that are homozygous for all added, exogenous polynucleotides that encode a polypeptide of the present invention. Back-crossing to a parental plant and outcrossing with a non-transgenic plant are also contemplated.
• the transformation or integration of the polynucleotide into the plant genome is confirmed by various methods such as analysis of polynucleotides, polypeptides and metabolites associated with the integrated sequence.
• PCR analysis is a rapid method to screen cells, tissue or shoots for the presence of incorporated gene at the earlier stage before transplanting into the soil (Sambrook and Russell (2001) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York. PCR is carried out using oligonucleotide primers specific to the nucleotide of interest or Agrobacterium vector background, etc. Introduction of DNA may be confirmed by Southern blot analysis of genomic DNA (Sambrook and Russell (2001) supra). In general, total DNA is extracted from the cell or organism, digested with appropriate restriction enzymes, fractionated in an agarose gel and transferred to a nitrocellulose or nylon membrane. The membrane or blot then is probed with, for example, radiolabeled 32 P-labeled target DNA fragment to confirm the integration of introduced DNA into the plant genome according to standard techniques (Sambrook and Russell (2001) supra).
• RNA is isolated from specific tissues of the cell or organism, fractionated in a formaldehyde agarose gel, and blotted onto a nylon filter according to standard procedures that are routinely used in the art (Sambrook and Russell (2001) supra). Expression of RNA encoded by the polynucleotide of the present invention is then tested by hybridizing the filter to a radioactive probe derived from the sequence of interest, by methods known in the art (Sambrook and Russell (2001) supra).
• Western blot and biochemical assays and the like may be carried out on the transgenic plants to determine the presence of polypeptide encoded by the nucleotide(s) of interest by standard procedures (Sambrook and Russell, 2001,) using antibodies that bind to one or more epitopes present on the herbicide resistance polypeptide.
• the DNA coding sequence and amino acid sequence of the grg20 open reading frame are set forth as SEQ ID NO:7 and SEQ ID NO:8 of this application, respectively.
• This EPSPS is described in the art as from Sulfolobus solfataricus (American Type Culture Collection Accession No. 35092D).
• each enzyme was diluted to an appropriate assay concentration in buffer containing HEPES (50 mM, pH 7) and 50 mM KCl, and then incubated for 15 minutes at 10, 20, 30, 40, 50 or 60 0 C. Following incubation, each enzyme was heated to 90 0 C for 1 minute to denature the enzyme, and then cooled to 4°C.
• each enzyme was diluted to an appropriate assay concentration in buffer containing HEPES (50 mM, pH 7) and 50 mM KCl, and then incubated for 15 minutes with buffers calibrated to pHs ranging from pH 6.0 to pH 8.0. Following incubation, each enzyme was heated to 90 0 C for 1 minute to denature the enzyme, and then cooled to 4°C.
• GRGl has a higher percentage activity then GRG23.
• a plant cell expressing both GRGl and GRG23 will have improved activity at a pH range between pH 6.0 and pH 7.5 as compared to a plant cell expressing GRGl or GRG2 alone.
• each enzyme was diluted to an appropriate assay concentration in buffer containing HEPES (50 mM, pH 7) and 50 mM KCl, and then incubated for 15 minutes with buffers supplemented with various amounts of KCL ranging from 50 mM to 200 mM. Following incubation, each enzyme was heated to 90 0 C for 1 minute to denature the enzyme, and then cooled to 4°C.
• Maize ears are best collected 8-12 days after pollination. Embryos are isolated from the ears, and those embryos 0.8-1.5 mm in size are used for transformation. Embryos are plated scutellum side-up on a suitable incubation media.
• DN62A5S media is one such media and is prepared as follows: combine 3.98 g/L N6 salts; 1 mL/L (of 100Ox stock) N6 vitamins; 800 mg/L L-asparagine; 100 mg/L myo-inositol; 1.4 g/L L-proline; 100 mg/L casamino acids; 50 g/L sucrose; 1 mL/L (of 1 mg/mL stock) 2,4-D); adjust to pH 5.8 with IN KOH/1N KCl; add gelrite (Sigma) at a concentration of 3g/L; after autoclaving and cooling to 50 0 C, 2 ml/L of a 5 mg/ml stock solution of Silver Nitrate (Phytotechnology Labs) is added and media is poured into plates. Media and salts other than DN62A5S are also suitable and are known in the art. Embryos are incubated overnight at 25°C in the dark. Embryos may also be incubated for variable
• the resulting explants are transferred to mesh squares (30-40 per plate), transferred onto osmotic media for about 30-45 minutes, then transferred to a beaming plate (see e.g., PCT International Publication No. WO/0138514 and U.S. Patent No. 5,240,842).
• DNA constructs designed to express a first and second EPSP synthase with varying kinetic optima in plant cells are accelerated into plant tissue using an aerosol beam accelerator, using conditions essentially as described in PCT International Publication No. WO 01/38514. After beaming, embryos are incubated for about 30 minutes on osmotic media, and placed onto incubation media overnight at 25°C in the dark. Care is taken to avoid unduly damaging beamed explants, for example, by incubating embryos for at least 24 hours prior to transfer to recovery media. Embryos are then spread onto recovery period media, for about 5 days, 25°C in the dark, and then transferred to a selection media.
• Explants are incubated in selection media for up to eight weeks, depending on the nature and characteristics of the particular selection utilized. After the selection period, the resulting callus is transferred to embryo maturation media, until the formation of mature somatic embryos is observed. The resulting mature somatic embryos are then placed under low light, and the process of regeneration is initiated by methods known in the art. The resulting shoots are allowed to root on rooting media, and the resulting plants are transferred to nursery pots and propagated as transgenic plants.
• the plants are assayed for improved resistance to glyphosate over a broader range of a physiological or environmental condition (e.g., temperature, pH, concentration of a substrate for said first and second polypeptide, concentration of a cofactor for said first and second polypeptide, concentration of free radicals or free radical donors, concentration of an inhibitor of said first and second polypeptide, or concentration of a catalyst of said first and second polypeptide) than when only a single ESP sequence is expressed.
• a physiological or environmental condition e.g., temperature, pH, concentration of a substrate for said first and second polypeptide, concentration of a cofactor for said first and second polypeptide, concentration of free radicals or free radical donors, concentration of an inhibitor of said first and second polypeptide, or concentration of a catalyst of said first and second polypeptide
• a physiological or environmental condition e.g., temperature, pH, concentration of a substrate for said first and second polypeptide, concentration of a cofactor for said first and second polypeptide, concentration of free radicals
• Ears are collected 8-12 days after pollination. Embryos are isolated from the ears, and those embryos about 0.8-1.5 mm in size are used for transformation. Embryos are plated scutellum side -up on a suitable incubation media, and incubated overnight at 25°C in the dark. Embryos may also be incubated for variable times as sufficient to achieve plant transformation. Embryos are contacted with an Agrobacterium strain containing the appropriate vectors having two EPSP synthase sequences that are capable of conferring resistance to glyphosate and having varying kinetic optima for Ti plasmid mediated transfer for about 5-10 minutes, and then plated onto co-cultivation media for about 3 days (25°C in the dark).
• explants After co-cultivation, explants are transferred to recovery period media for about five days (at 25°C in the dark). Explants are incubated in selection media for up to eight weeks, depending on the nature and characteristics of the particular selection utilized. After the selection period, the resulting callus is transferred to embryo maturation media, until the formation of mature somatic embryos is observed. The resulting mature somatic embryos are then placed under low light, and the process of regeneration is initiated as known in the art. The resulting shoots are allowed to root on rooting media, and the resulting plants are transferred to nursery pots and propagated as transgenic plants.
• the plants are assayed for improved resistance to glyphosate over a broader range of a physiological or environmental condition (e.g., temperature, pH, concentration of a substrate for said first and second polypeptide, concentration of a cofactor for said first and second polypeptide, concentration of free radicals or free radical donors, concentration of an inhibitor of said first and second polypeptide, or concentration of a catalyst of said first and second polypeptide) than when only a single ESP sequence is expressed.
• a physiological or environmental condition e.g., temperature, pH, concentration of a substrate for said first and second polypeptide, concentration of a cofactor for said first and second polypeptide, concentration of free radicals or free radical donors, concentration of an inhibitor of said first and second polypeptide, or concentration of a catalyst of said first and second polypeptide
• a physiological or environmental condition e.g., temperature, pH, concentration of a substrate for said first and second polypeptide, concentration of a cofactor for said first and second polypeptide, concentration of free radicals

Landscapes

• Genetics & Genomics (AREA)
• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Engineering & Computer Science (AREA)
• Zoology (AREA)
• Wood Science & Technology (AREA)
• Organic Chemistry (AREA)
• Biomedical Technology (AREA)
• Chemical & Material Sciences (AREA)
• Biotechnology (AREA)
• General Engineering & Computer Science (AREA)
• Molecular Biology (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Microbiology (AREA)
• Physics & Mathematics (AREA)
• Plant Pathology (AREA)
• Biophysics (AREA)
• Biochemistry (AREA)
• General Health & Medical Sciences (AREA)
• Cell Biology (AREA)
• Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
• Enzymes And Modification Thereof (AREA)

Applications Claiming Priority (2)

Publications (2)

Family

ID=39721747

Family Applications (1)

Country Status (5)

Families Citing this family (1)

Citations (3)

• 2007
  • 2007-07-20 EP EP07813164A patent/EP2117293A4/de not_active Withdrawn
  • 2007-07-20 BR BRPI0721374-3A2A patent/BRPI0721374A2/pt not_active IP Right Cessation
  • 2007-07-20 WO PCT/US2007/073988 patent/WO2008105905A2/en active Application Filing
  • 2007-07-20 AU AU2007347785A patent/AU2007347785A1/en not_active Abandoned
  • 2007-07-24 AR ARP070103292 patent/AR062052A1/es unknown

Patent Citations (3)

Non-Patent Citations (2)

Also Published As

Similar Documents

Legal Events